PRODUCT DETAIL

Lapatinib Stada 250 mg filmom obalené tablety

Code

2553F

MA number

44/0038/26-S

Product Form:

tbl flm 140 (2x70) x250 mg (blis.Al/OPA/Al/PVC-multibal.)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Mutual recognition procedure

MAH, country:

STADA Arzneimittel AG, Germany

Therapeutic Class:

44 - CYTOSTATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01	ANTINEOPLASTIC AGENTS
L01E	Protein kinase inhibitors
L01EH	Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
L01EH01	Lapatinib

Shelf life:

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to restricted medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	25.02.2026
Validity:	25.02.2031
SPC:	SPC_Lapatinib Stada 250 mg filmom obalené tablety_tbl flm_02/2026_REG.pdf
PIL:	PIL_Lapatinib Stada 250 mg filmom obalené tablety_tbl flm_02/2026_REG.pdf
Safety feature	Yes
Data update:	26.02.2026